File Download
Patent History
- ApplicationUS 12/113056 2008-04-30
- PublicationUS 2009274709 2009-11-05
Patent Family
Supplementary
-
Citations:
- Appears in Collections:
published patent: Lipocalin-2 As A Prognostic and Diagnostic Marker For Heart And Stroke Risks
Title | Lipocalin-2 As A Prognostic and Diagnostic Marker For Heart And Stroke Risks |
---|---|
Priority Date | 2008-04-30 US 12/113056 |
Inventors | |
Issue Date | 2009 |
Citation | US Published patent application US 2009274709. Washington, DC: US Patent and Trademark Office (USPTO), 2009 How to Cite? |
Abstract | Methods and apparatus are disclosed for the measurement of lipocalin-2 in body fluids (including but not limited to blood, serum, plasma, urine, saliva, tear, etc.) by an assay such as an immunoassay or an immunotest for (1) the prediction of risk of future cardiovascular diseases; and (2) the determination of the likelihood that certain individuals will benefit to a greater or lesser extent from the use of certain treatments designed to prevent and/or treat cardiovascular diseases. |
Persistent Identifier | http://hdl.handle.net/10722/176982 |
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2012-11-30T08:38:53Z | - |
dc.date.available | 2012-11-30T08:38:53Z | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | US Published patent application US 2009274709. Washington, DC: US Patent and Trademark Office (USPTO), 2009 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/176982 | - |
dc.description.abstract | Methods and apparatus are disclosed for the measurement of lipocalin-2 in body fluids (including but not limited to blood, serum, plasma, urine, saliva, tear, etc.) by an assay such as an immunoassay or an immunotest for (1) the prediction of risk of future cardiovascular diseases; and (2) the determination of the likelihood that certain individuals will benefit to a greater or lesser extent from the use of certain treatments designed to prevent and/or treat cardiovascular diseases. | en_HK |
dc.title | Lipocalin-2 As A Prognostic and Diagnostic Marker For Heart And Stroke Risks | en_HK |
dc.type | Patent | en_US |
dc.description.nature | published_or_final_version | en_US |
dc.contributor.inventor | Xu, A | en_HK |
dc.contributor.inventor | Wang, Y | en_HK |
dc.contributor.inventor | Renneberg Reinhard | en_HK |
dc.contributor.inventor | Cautherley, GWH | en_HK |
dc.contributor.inventor | Chan, CPY | en_HK |
dc.contributor.inventor | Lehmann, M | - |
patents.identifier.application | US 12/113056 | en_HK |
patents.description.assignee | VERSITECH LIMITED AND R & C BIOGENIUS LIMITED | en_HK |
patents.description.country | United States of America | en_HK |
patents.date.publication | 2009-11-05 | en_HK |
patents.identifier.hkutechid | Medi-2008-00273 | - |
patents.date.application | 2008-04-30 | en_HK |
patents.date.priority | 2008-04-30 US 12/113056 | en_HK |
patents.description.cc | US | en_HK |
patents.identifier.publication | US 2009274709 | en_HK |
patents.relation.family | CN 102026655 (A) 2011-04-20 | en_HK |
patents.relation.family | EP 2300048 (A1) 2011-03-30 | en_HK |
patents.relation.family | JP 2011519037 (A) 2011-06-30 | en_HK |
patents.relation.family | US 2009274709 (A1) 2009-11-05 | en_HK |
patents.relation.family | US 8030097 (B2) 2011-10-04 | en_HK |
patents.relation.family | WO 2009132510 (A1) 2009-11-05 | en_HK |
patents.description.kind | A1 | en_HK |
patents.type | Patent_published | en_HK |